from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0997/-

LFCtreatmentdescriptionclass of inhibitor

0.160

Amikacinug/mL Amikacintranslation

-0.281

Cap5-10ug/mL Capreomycintranslation

-0.366

Rox10-50 ug/mL Roxithromycintranslation

-0.186

SM2-5 ug/mL Streptomycintranslation

0.873

Tet5-10 ug/mL Tetracyclinetranslation

0.333

Rif0.2-5ug/mL Rifampicintranscription

-0.589

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.608

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.073

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

2.219

CPZ10-50 ug/mL Chlorpromazinerespiration

0.457

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.412

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.734

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.581

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.146

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.373

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.107

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.228

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.868

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.773

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.217

KCN5-20 ug/mL Potassium cyaniderespiration

-1.221

NaN30.2-2 mM Sodium aziderespiration

-0.979

Nigericin50 uM Nigericinrespiration

-0.027

TRC10-150 ug/mL Triclosanrespiration

3.634

TRZ10-25 ug/mL Thioridazinerespiration

-0.301

Valinomycin0.5-10 uM Valinomycinrespiration

-1.352

ZnSO42 mM ZnSO4respiration

-0.610

menadione6-10 ug/mL Menadionerespiration

0.476

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.470

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.503

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.708

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.429

NRP_1Non-replicating persistence stage 1dosRassociated

0.485

Amp0.2mg/mL AmpicillincellWall

0.695

Cephalexin20-100 ug/mL CephalexincellWall

-0.765

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.058

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.158

EMB10-20 ug/mL EthambutolcellWall

-0.100

Eta12-40 ug/mL EthionamidecellWall

-0.008

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.355

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.522

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.117

BZA0.12 mg/mL BenzamidearomaticAmides

-0.064

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.016

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.242

H2O24 mM hydrogen peroxideDNAdamaging

0.964

Levo10 ug/mL LevofloxacinDNAdamaging

-0.541

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.028

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.730

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.030

UVUV-irradiationDNAdamaging

0.271

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.880

Antimycin12.5-50 ug/mL Antimycin A?

-0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.551

PA_110-50 ug/mL Antitubercular compound PA-1?

0.094

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.693

PA8240.2-2 ug/mL PA-824?

0.782

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.818

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.174

Verapamil50 uM Verapamil?

0.031

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.528

methoxatin10-20 ug/mL Methoxatin?